2(acute)-Deoxyguanosine - CAS 961-07-9
Not Intended for Therapeutic Use. For research use only.
Category:
Inhibitor
Product Name:
2(acute)-Deoxyguanosine
Catalog Number:
961-07-9
Synonyms:
Deoxyguanosine; Guanine deoxyriboside
CAS Number:
961-07-9
Description:
2(acute)-Deoxyguanosine is composed of the purine nucleoside guanine linked by its N9 nitrogen to the C1 carbon of deoxyribose. It is a purine nucleoside that upon sequential phosphoylation (kinases) forms dGTP which is used by DNA polymerases and reverse transcriptases to synthesis DNA(s). It is the most electron rich of the four canonical bases and includes many nucleophilic sites which are susceptible to oxidative damage. It is useful reagents to study mechanisms of oxidative damage to nucleosides and nucleotides.
Molecular Weight:
267.24
Molecular Formula:
C10H13N5O4
COA:
Inquire
MSDS:
Inquire
Targets:
Others
Chemical Structure
CAS 961-07-9 2(acute)-Deoxyguanosine

Related Products


CAS 856676-23-8 Choline Fenofibrate

Choline Fenofibrate
(CAS: 856676-23-8)

Choline Fenofibrate is the choline salt of fenofibric acid under clinical development as a combination therapy with rosuvastatin for the management of dyslipide...

CC-12074
(CAS: 460741-57-5)

A Metabolite of Pomalidomide.

CAS 5949-44-0 Testosterone undecanoate

Testosterone undecanoate
(CAS: 5949-44-0)

A metabolite of Testosterone, which is a promising androgen for male hormonal contraception.

FR-217840
(CAS: 848444-16-6)

FR-217840 is a matrix metalloproteinase inhibitor. It can suppress joint destruction. FR217840 may have potential as a novel anti-rheumatic drug.

CAS 4871-97-0 Curcumol

Curcumol
(CAS: 4871-97-0)

Curcumol is a pure monomer isolated from Rhizoma Curcumaeis with antitumor activities.

CAS 486-62-4 Ononin

Ononin
(CAS: 486-62-4)

Ononin is an isoflavonoid from Ononis natrix L, can inhibit the growth of pathogen.

CAS 74397-12-9 Limaprost

Limaprost
(CAS: 74397-12-9)

Limaprost is a potent platelet adhesion inhibitor and vasodilator that increases blood flow and inhibits platelet aggregation. It is an analog of prostaglandin ...

CAS 144-75-2 Adesulfone Sodium

Adesulfone Sodium
(CAS: 144-75-2)

Sulfoxone sodium is an anti-leprosy drug which was introduced in Japan in 1948.

CAS 1477949-42-0 CAY10683

CAY10683
(CAS: 1477949-42-0)

Santacruzamate A (CAY10683) is a potent and selective HDAC inhibitor with IC50 of 119 pM for HDAC2, >3600-fold selectivity over other HDACs.

CAS 50924-49-7 Mizoribine

Mizoribine
(CAS: 50924-49-7)

Mizoribine,Mizoribine (INN, trade name Bredinin) is an immunosuppressive drug. The compound was first observed in Tokyo, Japan, in 1971. It is a natural product...

CAS 3055-99-0 Polidocanol

Polidocanol
(CAS: 3055-99-0)

A nonionic surfactant.

CAS 131-53-3 Dioxybenzone

Dioxybenzone
(CAS: 131-53-3)

Dioxybenzone, a phenol derivative, could be widely used to block UVB and UVA in sunscreen products.

CAS 75-80-9 Tribromoethanol

Tribromoethanol
(CAS: 75-80-9)

Tribromoethanol is a sedative. It is used to anesthetize laboratory animals, particularly rodents, prior to surgery. It has the brand name Avertin as a solution...

CAS 28860-95-9 Carbidopa

Carbidopa
(CAS: 28860-95-9)

Carbidopa is an aromatic-L-amino-acid decarboxylase inhibitor with an IC50 of 29 ± 2 μM.

CAS 1786-81-8 Prilocaine hydrochloride

Prilocaine hydrochloride
(CAS: 1786-81-8)

Prilocaine hydrochloride is a local anesthetic of the amino amide type.

CAS 84687-42-3 Astragaloside III

Astragaloside III
(CAS: 84687-42-3)

Astragaloside III is a saponin found in the root of Astragalus membranaceus (Fisch.) Bunge, which is known as huáng qí in Traditional Chinese Medicine. It has c...

CAS 120279-96-1 Dorzolamide

Dorzolamide
(CAS: 120279-96-1)

Dorzolamide is a potent carbonic anhydrase II inhibitor with an IC50 value of 0.16 nM on human erythrocyte carbonic anhydrase II in vitro. It has been found to ...

CAS 191282-48-1 C75 trans

C75 trans
(CAS: 191282-48-1)

trans-Tetrahydro-4-methylene-2-octyl-5-oxo-3-furancarboxylic Acid is a well-known fatty acid synthase (FAS) inhibitor. Studies show that trans-Tetrahydro-4-meth...

NS-2214
(CAS: 171655-92-8)

NS-2214, an azabicyclo compound, has been found to be a dopamine uptake inhibitor that was once studied in the treatment of Parkinson's disease.

CAS 3650-09-7 Carnosic Acid

Carnosic Acid
(CAS: 3650-09-7)

Carnosic acid has medicinal properties, is a potent antioxidant and protects skin cells against UV-A radiation (photoprotection). Studies in animals have also f...

Reference Reading


1.Acute kidney injury in high-risk cardiac surgery patients: roles of inflammation and coagulation.
Scrascia G1, Rotunno C, Simone S, Montemurno E, Amorese L, De Palo M, Castellano G, Pertosa GB, Gesualdo L, Paparella D. J Cardiovasc Med (Hagerstown). 2015 Dec 11. [Epub ahead of print]
AIMS: Acute kidney injury (AKI) is a common complication following cardiac surgery. Cardiopulmonary bypass elicits coagulation and inflammation activation and oxidative stress, all involved in AKI but never simultaneously assessed. We aimed to evaluate relations between oxidative stress, inflammatory and coagulation systems activation and postoperative renal function in patients with normal preoperative renal function.
2.Green Tea Polyphenol Prevents Diabetic Rats From Acute Kidney Injury After Cardiopulmonary Bypass.
Funamoto M1, Masumoto H1, Takaori K2, Taki T1, Setozaki S1, Yamazaki K1, Minakata K1, Ikeda T3, Hyon SH4, Sakata R1. Ann Thorac Surg. 2016 Apr;101(4):1507-13. doi: 10.1016/j.athoracsur.2015.09.080. Epub 2015 Dec 8.
BACKGROUND: Acute kidney injury (AKI) is a common complication accompanying cardiopulmonary bypass (CPB) and is independently associated with increased morbidity and death. Diabetes mellitus increases the risk for AKI after CPB. Epigallocatechin-3-gallate (EGCG) is a major component of the polyphenolic fraction of green tea, which possesses cardioprotective activities, as previously reported. We hypothesized that EGCG also possesses a renoprotective effect through its diverse biochemical properties and assessed the effect on renal function after CPB for diabetic rats.
3.Resveratrol alleviates the cytotoxicity induced by the radiocontrast agent, ioxitalamate, by reducing the production of reactive oxygen species in HK-2 human renal proximal tubule epithelial cells in vitro.
Huang YT1, Chen YY2, Lai YH3, Cheng CC4, Lin TC4, Su YS3, Liu CH5, Lai PC6. Int J Mol Med. 2016 Jan;37(1):83-91. doi: 10.3892/ijmm.2015.2404. Epub 2015 Nov 9.
Radiocontrast-induced nephropathy (RIN) is one of the leading causes of hospital-acquired acute kidney injury (AKI). The clinical strategies currently available for the prevention of RIN are insufficient. In this study, we aimed to determine whether resveratrol, a polyphenol phytoalexin, can be used to prevent RIN. For this purpose, in vitro experiments were performed using a human renal proximal tubule epithelial cell line (HK-2 cells). Following treatment for 48 h, the highly toxic radiocontrast agent, ioxitalamate, exerted cytotoxic effects on the HK-2 cells in a concentration-dependent manner, as shown by MTT assay. The half maximal inhibitory concentration (IC50) was found to be approximately 30 mg/ml. Flow cytometry also revealed a marked increase in the number of apoptotic cells following exposure to ioxitalamate. In addition, the number of necrotic, but not necroptotic cells was increased. However, treatment with resveratrol (12.
4.Increased activities of both superoxide dismutase and catalase were indicators of acute depressive episodes in patients with major depressive disorder.
Tsai MC1, Huang TL2. Psychiatry Res. 2016 Jan 30;235:38-42. doi: 10.1016/j.psychres.2015.12.005. Epub 2015 Dec 8.
Oxidative stress may play an important role in the pathophysiology of major depressive disorder (MDD). The aim of this study was to investigate the serum levels of oxidative stress biomarkers and S100B in patients with MDD in an acute phase, and evaluate the changes in superoxide dismutase (SOD), protein carbonyl content (PCC), glutathione peroxidase (GPX), 8-hydroxy 2'-deoxyguanosine after treatment (8-OHdG), catalase (CAT), thiobarbituric acid reactive substances (TBARS) and S100B. We consecutively enrolled 21 MDD inpatients in an acute phase and 40 healthy subjects. Serum oxidative stress markers were measured with assay kits. Serum SOD and CAT activities in MDD patients in an acute phase were significantly higher than those of healthy subjects, and serum PCC levels were significantly lower. The HAM-D scores had a significantly positive association with S100B levels. Eighteen depressed patients were followed up, and there was no significant difference among all of the markers after treatment.